[Combined treatment, polychemotherapy and amino-hydroxybutylidene-diphosphonate, of a patient with multiple myeloma: remission and long survival].
Attardo-Parrinello
G
G
Merlini
G
G
Crema
F
F
Fiorentini
M L
ML
Mazzone
A
A
Cotti-Piccinelli
E
E
D019386:Alendronate; D000971:Antineoplastic Combined Chemotherapy Protocols; D003520:Cyclophosphamide / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D004164:Diphosphonates; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan; D011241:Prednisone; D019386:Alendronate
Trattamento combinato polichemioterapia-aminoidrossibutilidene-difosfonato in un paziente affetto da mieloma multiplo: remissione completa e lunga sopravvivenza.